Genesis' CEO Gong Xiang Chen was elected “the Recruitment Program of Global Experts”, which would bring in overseas top talents to China.
On May 16, 2016, GENESIS obtained New Drug and Production Approval of CFDA for Mycoplasma Pneumoniae Antigen Rapid Diagnostic Test Kit.
GENESIS' paper,Scientific Reports:Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immunochromatographic antigen assay.
T.B. Identification kit and M. P. Antigen Test Kit are the two“only-one” available products in China.